StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
IVPR

Inspire Veterinary Partners, Inc.

IVPR OTC Agricultural Services EDGAR ↗
$0.00
-0.00 -50.00%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$376
Revenue (TTM) ⓘ
$15.6M
Net income (TTM) ⓘ
-$11.9M
EPS (TTM) ⓘ
—
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
-$10.2M
Cash ⓘ
$576K
Total assets ⓘ
$24.0M
Gross margin ⓘ
—
52-week range ⓘ
$0.00 – $1.06

AI briefing

from the latest 10-K, 10-Q and 8-K events

Inspire Veterinary Partners, Inc. is a money-losing owner and operator of thirteen small animal veterinary hospitals across nine U.S. states, struggling with liquidity and facing potential delisting.

What they do

Inspire Veterinary owns and operates thirteen veterinary hospitals in nine states, focusing on small animal general practice with services including preventive care, soft tissue surgery, and alternative therapies. The company completed its IPO in August 2023 and trades on Nasdaq under 'IVP'. It seeks growth through acquisitions of existing hospitals, leveraging a distributed leadership structure. As of September 30, 2025, it had $24.0 million in total assets and $19.8 million in total liabilities.

Revenue drivers

  • Veterinary services — Revenue primarily from veterinary hospital services; quarterly revenue rose from $3.3M (Dec 2024) to $4.3M (Sep 2025).
  • Preventive care and surgery — Includes annual exams, dental, radiology, bloodwork, spays/neuters, and soft tissue procedures; core offerings across all hospitals.
  • Alternative therapies — Acupuncture, chiropractic, and other wellness services offered at many locations, adding incremental revenue.

Recent performance

Revenue for fiscal 2024 was $16.6M, down slightly from $16.7M in 2023; net loss for 2024 was $14.3M. Latest quarterly revenue increased to $4.3M for both Q2 and Q3 2025, up from $3.3M in Q4 2024. Operating cash flow for 2024 was -$10.0M, worse than -$3.8M in 2023. As of September 30, 2025, cash and cash equivalents were $0.34M, with $11.8M long-term debt and $4.2M shareholder equity.

Strategy

Management plans to continue acquiring veterinary hospitals, targeting those with financial track record and growth potential, and is not limited to one geographic area. They aim to leverage a distributed leadership structure to integrate acquisitions. They also expect to raise additional capital, as indicated by recent financing agreements and equity sales. The company is focused on achieving profitability and addressing going-concern concerns.

Risks

  • Going concern risk — Independent auditors included a going concern explanatory paragraph for fiscal 2024; low cash and negative cash flow raise substantial doubt about ability to continue.
  • Continuing losses — The company has never generated a net profit, with accumulated deficit of $36.4M as of December 2024.
  • Delisting risk — Recent 8-K filings indicate a delisting notice (January 2026) and potential Nasdaq listing-rule failure.
  • Need for additional capital — The company expects to raise more capital but cannot assure it will secure necessary funding on acceptable terms.

Outlook

Management expects to continue incurring net losses for the foreseeable future due to acquisition-related costs and expansion. They plan to raise additional capital, as evidenced by recent equity sales and material agreements. The company's ability to continue hinges on generating positive cash flow and reducing expenses, but no specific guidance is provided.

Recent SEC filings

40 most recent
Annual, quarterly & current reports